Inventor · disambiguated record
Michael Rugaard Jensen
Also filed as: JENSEN MICHAEL RUGAARD
1 granted patent·19 pending applications·0 citations·filing 2006–2016
14Inventor score
Top patents by PatentIndex Score
20 records- 0168US2011236379A1Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitorGARCIA-ECHEVERRIA CARLOS·Filed 2009·Application pending·0 cites
- 0262US2014328834A1Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitorNOVARTIS AG·Filed 2014·Application pending·0 cites
- 0360US8906936B2Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclohexyl-2-{2-[4-(4-fluoro-benzoyl)-thiazol-2-yl]-pyrrolidin-1-yl}-2-oxo-ethyl)-2-methylamino-propionamide or pharmaceutically acceptable salt(s) thereofNOVARTIS AG·Filed 2013·Granted Dec 9, 2014·0 cites·6 claims
- 0458US2010210650A1Isoxazole compound for the treatment of cancerNOVARTIS AG·Filed 2008·Application pending·0 cites
- 0557US2009005411A1Combinations of Organic CompoundsNOVARTIC AG·Filed 2006·Application pending·0 cites
- 0656US2011230444A1Pharmaceutical combination comprising a hsp 90 inhibitor and a mtor inhibitorNOVARTIS AG·Filed 2009·Application pending·0 cites
- 0755US2012219550A1Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitorGARCIA-ECHEVERRIA CARLOS·Filed 2012·Application pending·0 cites
- 0853US2013085153A1Combination of an iap inhibitor and a taxane for the treatment of a proliferative diseaseJENSEN MICHAEL RUGAARD·Filed 2012·Application pending·0 cites
- 0952US2010324083A1Combinations of Organic CompoundsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 1052US2015209362A1Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitorGARCIA-ECHEVERRIA CARLOS·Filed 2015·Application pending·0 cites
- 1152US2011230499A1Hsp90 inhibitors for therapeutic treatmentNOVARTIS AG·Filed 2009·Application pending·0 cites
- 1251US2014288075A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2014·Application pending·0 cites
- 1347US2016346292A1Pharmaceutical combinations comprising a pyrido [4,3-d] pyrimidine derived hsp90-inhibitor and a her2 inhibitorGARCIA-ECHEVERRIA CARLOS·Filed 2016·Application pending·0 cites
- 1447US2012214813A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2012·Application pending·0 cites
- 1547US2014242088A1Hsp90 inhibitor combinationsGARCIA-ECHEVERRIA CARLOS·Filed 2014·Application pending·0 cites
- 1646US2016220576A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2016·Application pending·0 cites
- 1746US2012083496A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2011·Application pending·0 cites
- 1844US2016045513A1Isoxazole compound for the treatment of cancerCHENE PATRICK·Filed 2015·Application pending·0 cites
- 1941US2017049781A1Hsp90 inhibitor combinationsGARCIA-ECHEVERRIA CARLOS·Filed 2016·Application pending·0 cites
- 2031US2013045983A1Hsp90 inhibitors for therapeutic treatmentNOVARTIS AG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Rugaard Jensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →